Taiwan FDA registration d64d6efce90f79e460ef661c4c8b3c6b

Aesthetic β-Globulin Rapid Test Reagent (Unsterilized)

TW: 醫試美β-球蛋白快速檢驗試劑 (未滅菌)

Taiwan·Risk Class 1·Kaiwu Technology Co., Ltd. Nanke Factory·Registered Feb 10, 2014 – Feb 10, 2019Cancelled

Registration details

Analysis ID: d64d6efce90f79e460ef661c4c8b3c6b

Company information

Manufacturer: Kaiwu Technology Co., Ltd. Nanke Factory
Manufacturer Country: Taiwan, Province of China
Authorized Representative: Kaiwu Technology Co., Ltd. Nanke Factory

Product details

Intended Use: Limited to the first level identification range of the β-globulin immunoassay system (C.5160) of the medical device management method.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5160 β-球蛋白免疫試驗系統
Import Information: Domestic

Dates and status

Registration Date: Feb 10, 2014
Expiry Date: Feb 10, 2019
Cancellation Date: Feb 23, 2019

Cancellation information

Status: Logged out
Reason: 未展延而逾期者;;自請註銷

About this record

Access comprehensive regulatory information for Aesthetic β-Globulin Rapid Test Reagent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d64d6efce90f79e460ef661c4c8b3c6b and manufactured by Kaiwu Technology Co., Ltd. Nanke Factory. The authorized representative in Taiwan is Kaiwu Technology Co., Ltd. Nanke Factory.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.